Candriam S.C.A. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 363 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$904,830
-46.9%
13,546
-9.7%
0.01%
-71.4%
Q2 2019$1,705,000
-9.6%
15,0000.0%0.02%
-12.5%
Q1 2019$1,886,000
-7.3%
15,0000.0%0.02%
-22.6%
Q4 2018$2,035,00015,0000.03%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
KNOTT DAVID M 1,249,766$58,726,504,00011.17%
BVF INC/IL 1,108,763$52,101,00010.82%
GROW Partners, LLC 132,500$6,226,0005.58%
CARDINAL CAPITAL MANAGEMENT LLC /CT 936,825$44,021,0002.73%
First Light Asset Management, LLC 76,366$3,588,0002.45%
Healthcare Value Capital, LLC 50,000$2,350,0002.27%
OBERWEIS ASSET MANAGEMENT INC/ 168,337$7,910,0002.17%
RK Capital 174,283$8,190,0001.67%
Nichols Asset Management LLC 133,368$6,267,0001.30%
ASHFORD CAPITAL MANAGEMENT INC 108,289$5,089,0001.09%
View complete list of LIGAND PHARMACEUTICALS INC shareholders